St. Gallen International Breast Cancer Conference 2021
Learn about the current research on HR-positive, HER2-Positive, Triple-Negative MBC, and other MBC subtypes from the 2021 St. Gallen International Breast Cancer Conference.
Learn about the current research on HR-positive, HER2-Positive, Triple-Negative MBC, and other MBC subtypes from the 2021 St. Gallen International Breast Cancer Conference.
Learn more about our newest partners, and where you can find Metastatic Trial Search.
Find metastatic breast cancer-specific coverage from the 37th Annual Miami Breast Cancer Conference.
“Just-in-Time” trials are designed to be opened easily and quickly at any site where an eligible patient is identified. Learn how they work, and how they benefit both patients and investigators.
Learn about research on HR+ MBC treatment, including AKT inhibitors, oral SERDs, CDK 4/6 inhibitors, and more.
Learn about the side effects of brain tumor radiation, why you might experience a specific side effect, and how medications, diet, and lifestyle changes may help.
People in LGBTQI communities are believed to be at a higher risk for breast cancer. More research and better care is needed. You can help.
Investigational drugs may be available outside of a clinical trial. Read more about the Expanded Access program.